Skye Bioscience Other Long Term Liabilities (Quarterly) Analysis

Skye Bioscience, Inc. (SKYE)

1.08 +0.10 (+10.20%) USD | NASDAQ | Jan 14, 10:39

View Other Long Term Liabilities (Quarterly) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Perspective Therapeutics, Inc.	Upgrade
Theravance Biopharma, Inc.	Upgrade
Viking Therapeutics, Inc.	--
Kyntra Bio, Inc.	Upgrade
Myomo, Inc.	--